{"id":"glutethimide","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Disease of liver","Hyperbilirubinemia","Hyperkalemia","Hypochloremia","Hypoglycemic disorder","Hyponatremia","Hypothyroidism","Infectious disease","Liver function tests abnormal","Low blood pressure","Pregnancy, function","Surgical procedure","Traumatic injury"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T14:14:02.739671","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GLUTETHIMIDE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:46:49.353766+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:46:56.175485+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GLUTETHIMIDE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:46:56.996551+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: GABA-A receptor; anion channel positive modulator","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:46:57.578455+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1102/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:46:57.464835+00:00"}},"allNames":"glimid","offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"GABA-A receptor alpha-1/beta-3/gamma-2","modality":"Small Molecule"},"_scrapedAt":"2026-03-28T00:32:59.175Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:47:00.214298+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"indications":{"approved":[{"name":"Insomnia","diseaseId":"insomnia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["pubmed(502)","generics(6)","patents(0)","modality→Small Molecule"],"labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[],"trialDetails":[{"nctId":"NCT00309491","phase":"PHASE3","title":"Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients","status":"COMPLETED","sponsor":"Austrian Breast & Colorectal Cancer Study Group","startDate":"1990-12","conditions":"Early-stage Breast Cancer","enrollment":2021},{"nctId":"NCT00006371","phase":"PHASE2","title":"A Phase II Trial of Early Medical Adrenalectomy for \"D0.5\" Prostate Cancer","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2000-05","conditions":"Prostate Cancer","enrollment":2}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"_patentsChecked":true,"crossReferences":{"chemblId":"CHEMBL1102"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":502,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[{"date":"2023 May 10","pmid":"36868027","title":"New approach for barbiturates, phenytoin, methyprylon and glutethimide determination and fragmentation (UHPLC-MS/MS).","journal":"Journal of pharmaceutical and biomedical analysis"},{"date":"2021 Aug","pmid":"34396551","title":"Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank.","journal":"Journal of clinical pharmacology"},{"date":"2012 Jan","pmid":"21502792","title":"A study of the risk of mental retardation among children of pregnant women who have attempted suicide by means of a drug overdose.","journal":"Journal of injury & violence research"},{"date":"2006 Jun 15","pmid":"18970673","title":"Chiral separations of piperidine-2,6-dione analogues on Chiralpak IA and Chiralpak IB columns by using HPLC.","journal":"Talanta"},{"date":"2008 Feb-Mar","pmid":"18818183","title":"A study of the effects of large doses of glutethimide that were used for self-poisoning during pregnancy on human fetuses.","journal":"Toxicology and industrial health"}],"companionDiagnostics":[],"genericManufacturers":6,"_genericFilersChecked":true,"genericManufacturerList":["Halsey","Lannett","Ucb Inc","Upsher Smith Labs","Vitarine","Watson Labs"],"phase":"marketed","status":"approved","brandName":"Glimid","genericName":"GLUTETHIMIDE","companyName":"Sandoz","companyId":"","modality":"Small molecule","firstApprovalDate":"1976","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:47:00.214298+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}